These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35324781)

  • 1. Cell Culture Process Scale-Up Challenges for Commercial-Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products.
    Lee B; Jung S; Hashimura Y; Lee M; Borys BS; Dang T; Kallos MS; Rodrigues CAV; Silva TP; Cabral JMS
    Bioengineering (Basel); 2022 Feb; 9(3):. PubMed ID: 35324781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and Solutions for Commercial Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products.
    Lee B; Borys BS; Kallos MS; Rodrigues CAV; Silva TP; Cabral JMS
    Bioengineering (Basel); 2020 Mar; 7(2):. PubMed ID: 32231012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming bioprocess bottlenecks in the large-scale expansion of high-quality hiPSC aggregates in vertical-wheel stirred suspension bioreactors.
    Borys BS; Dang T; So T; Rohani L; Revay T; Walsh T; Thompson M; Argiropoulos B; Rancourt DE; Jung S; Hashimura Y; Lee B; Kallos MS
    Stem Cell Res Ther; 2021 Jan; 12(1):55. PubMed ID: 33436078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robust bioprocess design and evaluation of commercial media for the serial expansion of human induced pluripotent stem cell aggregate cultures in vertical-wheel bioreactors.
    Borys BS; Dang T; Worden H; Larijani L; Corpuz JM; Abraham BD; Gysel EJ; Malinovska J; Krawetz R; Revay T; Argiropoulos B; Rancourt DE; Kallos MS; Jung S
    Stem Cell Res Ther; 2024 Jul; 15(1):232. PubMed ID: 39075528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scalable Expansion of Pluripotent Stem Cells.
    Lavon N; Zimerman M; Itskovitz-Eldor J
    Adv Biochem Eng Biotechnol; 2018; 163():23-37. PubMed ID: 29085956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of oncolytic adenovirus and human mesenchymal stem cells in a single-use, Vertical-Wheel bioreactor system: Impact of bioreactor design on performance of microcarrier-based cell culture processes.
    Sousa MF; Silva MM; Giroux D; Hashimura Y; Wesselschmidt R; Lee B; Roldão A; Carrondo MJ; Alves PM; Serra M
    Biotechnol Prog; 2015; 31(6):1600-12. PubMed ID: 26289142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized serial expansion of human induced pluripotent stem cells using low-density inoculation to generate clinically relevant quantities in vertical-wheel bioreactors.
    Borys BS; So T; Colter J; Dang T; Roberts EL; Revay T; Larijani L; Krawetz R; Lewis I; Argiropoulos B; Rancourt DE; Jung S; Hashimura Y; Lee B; Kallos MS
    Stem Cells Transl Med; 2020 Sep; 9(9):1036-1052. PubMed ID: 32445290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suspension Culture of Human Induced Pluripotent Stem Cells in Single-Use Vertical-Wheel™ Bioreactors Using Aggregate and Microcarrier Culture Systems.
    Nogueira DES; Rodrigues CAV; Hashimura Y; Jung S; Lee B; Cabral JMS
    Methods Mol Biol; 2021; 2286():167-178. PubMed ID: 33381855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrodynamic modulation of pluripotent stem cells.
    Fridley KM; Kinney MA; McDevitt TC
    Stem Cell Res Ther; 2012 Nov; 3(6):45. PubMed ID: 23168068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commercial Scale Manufacturing of Allogeneic Cell Therapy.
    Pigeau GM; Csaszar E; Dulgar-Tulloch A
    Front Med (Lausanne); 2018; 5():233. PubMed ID: 30186836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying Shear Stress to Pluripotent Stem Cells.
    Wolfe RP; Guidry JB; Messina SL; Ahsan T
    Methods Mol Biol; 2016; 1341():377-89. PubMed ID: 25762292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational fluid dynamics modeling, a novel, and effective approach for developing scalable cell therapy manufacturing processes.
    Shafa M; Panchalingam KM; Walsh T; Richardson T; Baghbaderani BA
    Biotechnol Bioeng; 2019 Dec; 116(12):3228-3241. PubMed ID: 31483482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technological progress and challenges towards cGMP manufacturing of human pluripotent stem cells based therapeutic products for allogeneic and autologous cell therapies.
    Abbasalizadeh S; Baharvand H
    Biotechnol Adv; 2013 Dec; 31(8):1600-23. PubMed ID: 23962714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for the expansion of human induced pluripotent stem cells as aggregates in single-use Vertical-Wheel™ bioreactors.
    Nogueira DES; Rodrigues CAV; Carvalho MS; Miranda CC; Hashimura Y; Jung S; Lee B; Cabral JMS
    J Biol Eng; 2019; 13():74. PubMed ID: 31534477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioprocess development for mass production of size-controlled human pluripotent stem cell aggregates in stirred suspension bioreactor.
    Abbasalizadeh S; Larijani MR; Samadian A; Baharvand H
    Tissue Eng Part C Methods; 2012 Nov; 18(11):831-51. PubMed ID: 22559864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. End-to-End Platform for Human Pluripotent Stem Cell Manufacturing.
    Pandey PR; Tomney A; Woon MT; Uth N; Shafighi F; Ngabo I; Vallabhaneni H; Levinson Y; Abraham E; Friedrich Ben-Nun I
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated Closed-System Expansion of Pluripotent Stem Cell Aggregates in a Rocking-Motion Bioreactor.
    Davis BM; Loghin ER; Conway KR; Zhang X
    SLAS Technol; 2018 Aug; 23(4):364-373. PubMed ID: 29481762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Feeding Strategies on the Scalable Expansion of Human Pluripotent Stem Cells in Single-Use Stirred Tank Bioreactors.
    Kropp C; Kempf H; Halloin C; Robles-Diaz D; Franke A; Scheper T; Kinast K; Knorpp T; Joos TO; Haverich A; Martin U; Zweigerdt R; Olmer R
    Stem Cells Transl Med; 2016 Oct; 5(10):1289-1301. PubMed ID: 27369897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human pluripotent stem cell-derived products: advances towards robust, scalable and cost-effective manufacturing strategies.
    Jenkins MJ; Farid SS
    Biotechnol J; 2015 Jan; 10(1):83-95. PubMed ID: 25524780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microcarrier-based platforms for in vitro expansion and differentiation of human pluripotent stem cells in bioreactor culture systems.
    Badenes SM; Fernandes TG; Rodrigues CAV; Diogo MM; Cabral JMS
    J Biotechnol; 2016 Sep; 234():71-82. PubMed ID: 27480342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.